年別の研究成果
年別の研究成果
検索結果
-
2024
Corrigendum to “A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation–positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKI and platinum-based chemotherapy” [Lung Cancer 177 (2023) 44–50, (S0169500223000405), (10.1016/j.lungcan.2023.01.011)]
Takeda, M., Shimokawa, M., Nakamura, A., Nosaki, K., Watanabe, Y., Kato, T., Hayakawa, D., Tanaka, H., Takahashi, T., Oki, M., Tachihara, M., Fujimoto, D., Hayashi, H., Yamaguchi, K., Yamamoto, S., Iwama, E., Azuma, K., Hasegawa, K., Yamamoto, N. & Nakagawa, K., 7月 2024, In: Lung Cancer. 193, 107852.研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読
Open Access